Importantly, the A2B receptor agonists can be proposed as adjuvant therapy to the accepted pharmacological strategy with tPA and can be a promising strategy for decreasing the risk of hemorrhages during the treatment for ischemic stroke. This evidence concerns the gene PLAT and ischemic stroke.